Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NEUPOGEN 300 MCG

FILGRASTIM : 300 MCG · DIN 01968017 · AMGEN CANADA INC

Health Canada status: MARKETED

What is NEUPOGEN?

NEUPOGEN 300 MCG contains FILGRASTIM : 300 MCG. It is listed in the Health Canada Drug Product Database under DIN 01968017, held by AMGEN CANADA INC, supplied as SOLUTION for SUBCUTANEOUS ; INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 20-Jun-2002. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is NEUPOGEN used for?

NEUPOGEN® (filgrastim injection) is indicated for: Cancer Patients Receiving Myelosuppressive Chemotherapy, Patients with Acute Myeloid Leukemia, Cancer Patients Receiving Myeloablative Chemotherapy Followed by Bone Marrow Transplantation, Cancer Patients Undergoing Peripheral Blood Progenitor Cell (PBPC) Collection and Therapy, Patients with Severe Chronic Neutropenia (SCN), and Patients with HIV Infection.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN01968017
Brand nameNEUPOGEN
Generic / active ingredientFILGRASTIM : 300 MCG
ManufacturerAMGEN CANADA INC
Strength300 MCG
Dosage formSOLUTION
Route of administrationSUBCUTANEOUS ; INTRAVENOUS
SchedulePrescription
ATC codeL03AA02 FILGRASTIM
AHFS class20:16.00
BiosimilarNo
Health Canada statusMARKETED
Status date20-Jun-2002
Original market date1992-12-31 00:00:00

How is it stored and handled?

null

How is it supplied?

Vials: 1 mL vials (300 mcg/mL) in boxes of 10, 1.6 mL vials (300 mcg/mL) in boxes of 10. Prefilled Syringes (SingleJect®): 0.5 mL syringes (600 mcg/mL) in boxes of 10, 0.8 mL syringes (600 mcg/mL) in boxes of 10.

What can be used instead?

Other Canadian products sharing ATC code L03AA02 FILGRASTIM. 13 of 13 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
FILRA300 MCG / 0.5 MLSOLUTIONJAMP PHARMA CORPORATIONMARKETEDDIN 02556537
FILRA480 MCG / 0.8 MLSOLUTIONJAMP PHARMA CORPORATIONMARKETEDDIN 02556545
GRASTOFIL300 MCG / 0.5 MLSOLUTIONAPOTEX INCMARKETEDDIN 02441489
GRASTOFIL480 MCG / 0.8 MLSOLUTIONAPOTEX INCMARKETEDDIN 02454548
NEUPOGEN600 MCGSOLUTIONAMGEN CANADA INCMARKETEDDIN 02420104
NEUPOGEN600 MCGSOLUTIONAMGEN CANADA INCMARKETEDDIN 02420112
NIVESTYM300 MCGSOLUTIONPFIZER CANADA ULCMARKETEDDIN 02485591
NIVESTYM300 MCG / 0.5 MLSOLUTIONPFIZER CANADA ULCMARKETEDDIN 02485575
NIVESTYM480 MCG / 0.8 MLSOLUTIONPFIZER CANADA ULCMARKETEDDIN 02485583
NIVESTYM480 MCG / 1.6 MLSOLUTIONPFIZER CANADA ULCMARKETEDDIN 02485656

Who else supplies FILGRASTIM worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. FILGRASTIM appears in 138 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for NEUPOGEN

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for NEUPOGEN

Health Canada Drug Product Database (DPD), DIN 01968017. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.